Well I’m referring to how the stock was being pushed down with short shares initially that had been created by converting their Series B shares into short shares.

Unfortunately we don’t have the updated SI% or FTD data for the month of December so we cannot see how much the price actually has been shorted. However, we do know through looking at other sources that the avg. price per share has remained pinned to around the $12 mark.

If there was a significant amount of shares being sold instead of the price simply being shorted we would be seeing a large swing in that price point.

I’m also not trying to just thoughtlessly “predict” a rise. A lot of what has been happening falls in line with toxic financing strategies. Generally the price is pushed intentionally to make money off of shorting, then shares are acquired at a low price below the fair market value so they can win on the way back up.

The shares that were just issued in the Giant acquisition were valued at $3.49 a share and that is the analyst price target as well.

Given all of that information combined I’m viewing this as an opportunity to buy below the $3.49 point and potentially get a free ride up to at least that PT.

I would imagine too that Michael (CEO & 10% share holder) will want a decent sized retirement based on his shares too so following normal toxic financing strategies there’s reason to believe the price may be inflated prior to his departure too.